Experimental transmission of hepatitis B virus by semen and saliva. 1980

R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong

The ability of human semen and saliva to transmit hepatitis B virus (HBV) by parenteral and nonparenteral routes was studied. Semen, donated by a hepatitis B surface antigen (HBsAg)- and hepatitis B e antigen (HBeAg)-positive carrier, was administered to one gibbon by subcutaneous inoculation and to another by intravaginal instillation. Both developed HBsAg, followed by the development of antibody to HBsAg (anti-HBs) and antibody to hepatitis B core antigen (anti-HBc). Saliva from two donors who were HBsAg- and HBeAg-positive was pooled and administered subcutaneously to two gibbons and orally to five others. The animals inoculated subcutaneously developed HBsAg followed by anti-HBs, but none of the gibbons exposed orally developed evidence of HBV infection. Thus, semen and saliva of HBsAg carriers can be infectious, and venereal transmission of HBV by semen can occur. Transmission of HBV in saliva can also occur through breaks in the skin, but experimental transmission of HBV by saliva administered orally has not been accomplished.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006922 Hylobates A genus of the family HYLOBATIDAE consisting of nine species. The members of this genus inhabit rain forests in southeast Asia. They are arboreal and differ from other anthropoids in the great length of their arms and very slender bodies and limbs. Their major means of locomotion is by swinging from branch to branch by their arms. Hylobates means dweller in the trees. Gibbons,Gibbon
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
June 1977, Infection and immunity,
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
May 1987, The Journal of infectious diseases,
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
July 2005, Oral diseases,
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
January 1974, Lancet (London, England),
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
December 1983, Virology,
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
February 1974, Lancet (London, England),
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
February 2018, The Journal of general virology,
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
October 1972, Lancet (London, England),
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
July 2010, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP,
R M Scott, and R Snitbhan, and W H Bancroft, and H J Alter, and M Tingpalapong
May 1985, Journal of virological methods,
Copied contents to your clipboard!